US SB2246 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 24 2019 - 25% progression, died in committee
Action: 2019-07-24 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 24 2019 - 25% progression, died in committee
Action: 2019-07-24 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
Title
Allergy Testing Access Act of 2019
Sponsors
| Sen. Jerry Moran [R-KS] | Sen. Christopher Murphy [D-CT] | Sen. Catherine Cortez Masto [D-NV] | Sen. Shelley Capito [R-WV] |
| Sen. Gary Peters [D-MI] | Sen. Sherrod Brown [D-OH] | Sen. Tim Scott [R-SC] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-07-24 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB2009 (Related) 2019-04-02 - Referred to the Subcommittee on Health.
Subjects
Allergies
Health
Health care costs and insurance
Health care coverage and access
Medicaid
Medical tests and diagnostic methods
Medicare
Health
Health care costs and insurance
Health care coverage and access
Medicaid
Medical tests and diagnostic methods
Medicare
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/2246/all-info |
| Text | https://www.congress.gov/116/bills/s2246/BILLS-116s2246is.pdf |
